Mercia EIS Funds

Sarissa Biomedical - Media Coverage

Mercia's Portfolio company, Sarissa Biomedical, has been featured in the Daily Mail.

  • Test acts as a sensor for strokes and could save lives with quicker diagnoses
  • Stroke is a leading cause of death and disability in the UK with 100,000 a year
  • Most cases are ischaemic strokes caused by blood clots blocking the brain

Read more here.